Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable aminotransferase | 0.0161 | 0.5912 | 0.5 |
Mycobacterium leprae | PROBABLE ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRANSFERASE BIOA | 0.0161 | 0.5912 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0049 | 0.0794 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0049 | 0.0794 | 0.5 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.0161 | 0.5912 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0049 | 0.0794 | 0.5 |
Onchocerca volvulus | 0.0051 | 0.0889 | 0.5 | |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0049 | 0.0794 | 0.5 |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.0161 | 0.5912 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0161 | 0.5912 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0251 | 1 | 1 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0051 | 0.0889 | 0.0889 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0049 | 0.0794 | 0.5 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0251 | 1 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0251 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.0889 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0049 | 0.0794 | 0.5 |
Brugia malayi | hypothetical protein | 0.0049 | 0.0794 | 0.0794 |
Schistosoma mansoni | survival motor neuron protein | 0.0051 | 0.0889 | 0.5 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.0161 | 0.5912 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0049 | 0.0794 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0049 | 0.0794 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.